New Zealand markets closed

MRNA Oct 2023 100.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
7.700.00 (0.00%)
As of 03:14PM EDT. Market open.
Full screen
Previous close7.70
Expiry date2023-10-20
Day's range7.70 - 8.70
Contract rangeN/A
Open interestN/A
  • Motley Fool

    $10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years

    I favor holding onto these players for the long term to truly benefit from their earnings potential.

  • Motley Fool

    With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?

    The Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster shots from Moderna (NASDAQ: MRNA) and the COVID-19 booster that Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) collaborated on. While the news will certainly help the pharmaceutical companies' bottom lines, it's important to look deeper to see if any of these three stocks make a solid investment today. At first glance, Pfizer's stock appears to be a screaming deal.

  • Motley Fool

    2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

    Two candidates with loads of potential are Moderna (NASDAQ: MRNA) and Teladoc Health (NYSE: TDOC). Moderna's earnings soared over the past two years thanks to its blockbuster COVID-19 vaccine. Moderna has set out a plan that could result in $30 billion in sales down the road, which surpasses its peak of about $18 billion in coronavirus vaccine sales.